Interest Expense in USD of Dyne Therapeutics, Inc. from Q3 2024 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Dyne Therapeutics, Inc. quarterly Interest Expense history and growth rate from Q3 2024 to Q3 2025.
  • Dyne Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2025 was $2.9M.
Interest Expense, Quarterly (USD)

Dyne Therapeutics, Inc. Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $2.9M +$2.9M Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $94K Apr 1, 2025 Jun 30, 2025 10-Q 2025-07-28
Q3 2024 $0 Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.